SCHEMBL1059565

SCHEMBL1059565

C=CNC(=O)OC(C)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.53
LPAR1 Q92633 5/20 0.45
LPAR3 Q9UBY5 2/20 0.45
OPRM1 P35372 3/20 0.43
NAAA Q02083 1/20 0.42
HTT P42858 1/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.38
LTB4R Q15722 2/20 0.38
LTB4R2 Q9NPC1 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1059944 1.00 HCAR2 (0.53) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL4910822 0.85 HCAR2 (0.54) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL4919973 0.82 HCAR2 (0.51) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL9711985 0.80 OPRM1 (0.49) HCAR2LPAR1LPAR3OPRM1HTT
SCHEMBL8290955 0.79 HCAR2 (0.54) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL12125431 0.79 HCAR2 (0.54) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL10152007 0.79 HCAR2 (0.54) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL4924887 0.78 HCAR2 (0.48) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL23130383 0.77 HCAR2 (0.53) HCAR2LPAR1LPAR3OPRM1NAAA
SCHEMBL10125207 0.77 HCAR2 (0.53) HCAR2LPAR1LPAR3OPRM1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730152-B1 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME MITSUBISHI TANABE PHARMA CORP (JP) 2012-05-02 EP disclosed
US-8158640-B2 Tetrahydroquinoline derivatives and a process for preparing the same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-04-17 US disclosed
US-20110039828-A1 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-02-17 US disclosed
US-7872126-B2 Tetrahydroquinoline derivatives and a process for preparing the same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-01-18 US disclosed
US-20070082896-A1 Tetrahydroquinoline derivatives and a process for preparing the same TANABE SEIYAKU CO., LTD. 2007-04-12 US disclosed
EP-1730152-A2 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME TANABE SEIYAKU CO., LTD. (JP) 2006-12-13 EP disclosed
WO-2005095409-A2 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME TANABE SEIYAKU CO., LTD. (JP) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082896-A1 Tetrahydroquinoline derivatives and a process for preparing the same CETP, MTTP, NPC1L1 HCAR2 2348/4885LPAR1 3339/4885LPAR3 2680/4885
US-20110039828-A1 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME CETP, MTTP, NPC1L1 HCAR2 2348/4885LPAR1 3339/4885LPAR3 2680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.